Cardiomyopathy

BridgeBio Reports Improved Data for ATTR Cardiomyopathy Drug

Source – BridgeBio BridgeBio is preparing to seek FDA approval for its acoramidis drug to treat transthyretin amyloidosis (ATTR) cardiomyopathy, ...